Susquehanna International Group, LLP Atossa Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.09 - $1.52 $43,927 - $61,256	40,300 Added 12.58%	360,700 $548,000
Q2 2024 Aug 15, 2024	BUY	$1.03 - $2.1 $287,988 - $587,160	279,600 Added 685.29%	320,400 $381,000
Q1 2024 May 07, 2024	SELL	$0.8 - $1.89 $21,600 - $51,030	-27,000 Reduced 39.82%	40,800 $73,000
Q4 2023 Feb 14, 2024	BUY	$0.63 - $0.98 $30,996 - $48,216	49,200 Added 264.52%	67,800 $59,000
Q3 2023 Nov 14, 2023	SELL	$0.74 - $1.35 $39,146 - $71,415	-52,900 Reduced 73.99%	18,600 $13,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.28 $17,100 - $36,480	28,500 Added 66.28%	71,500 $90,000
Q1 2023 May 16, 2023	SELL	$0.59 - $0.91 $85,609 - $132,041	-145,100 Reduced 77.14%	43,000 $30,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.01 $53,800 - $108,676	-107,600 Reduced 36.39%	188,100 $99,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $8,774 - $12,197	-10,700 Reduced 3.49%	295,700 $245,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $1.28 $25,160 - $37,888	29,600 Added 10.69%	306,400 $334,000
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $306,915 - $481,110	-276,500 Reduced 49.97%	276,800 $346,000
Q4 2021 Feb 14, 2022	SELL	$1.6 - $3.27 $1.55 Million - $3.17 Million	-968,200 Reduced 63.63%	553,300 $885,000
Q3 2021 Nov 15, 2021	BUY	$2.89 - $6.4 $38,148 - $84,480	13,200 Added 0.88%	1,521,500 $4.96 Million
Q2 2021 Aug 11, 2021	BUY	$1.52 - $8.62 $893,608 - $5.07 Million	587,900 Added 63.87%	1,508,300 $9.53 Million
Q1 2021 May 17, 2021	BUY	$0.92 - $4.33 $806,932 - $3.8 Million	877,100 Added 2025.64%	920,400 $1.94 Million
Q4 2020 Feb 16, 2021	BUY	$0.85 - $2.43 $36,805 - $105,219	43,300 New	43,300 $41,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

26.5M

Call Options Held

466K

Put Options Held

91.8K

Black Rock Inc. New York, NY

9.2M
Shares

$9.47 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.6M
Shares

$6.8 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.81M
Shares

$2.9 Million
0.0% of portfolio
State Street Corp Boston, MA

1.73M
Shares

$1.78 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.31M
Shares

$1.35 Million
0.0% of portfolio

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account